Search

23 Feb 2024: STEM-PD uses human embryonic stem cells, a type of cell that can turn into almost any type of […]. Filed Under:12th October 2022. In research published today in Alzheimer’s & ... Filed Under:13th May 2022. The research, from the University of

23 Feb 2024: England Research Consortium.

23 Feb 2024: Filed Under:10th August 2021. Dr Timothy Rittman is the clinical lead of the QMIN-MC trial, which uses a machine learning algorithm developed by Prof Zoe Kourtzi, research lead at ... The new Fellows have been selected for their exceptional contributions

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Jelle van den Ameele. Jelle van den Ameele. ... In 2020, Jelle became a Wellcome Clinical Research Career Development Fellow at the Department of Clinical Neurosciences and MRC Mitochondrial Biology Unit

23 Feb 2024: Jess’ research has led to the launch of a clinical trial, which is testing a new treatment to slow down the […]. Filed Under:5th June 2019. Results indicate that early treatment ... MRC Clinical Director He joins the senior management team and will

23 Feb 2024: SOUND Laboratory. Marina Salorio-Corbetto. Marina is a Research Associate who has previously worked as a clinical audiologist. ... While at the Auditory Perception Group, Marina started collaborating with Dr Josephine Marriage as a Research Audiologist.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. CCMR2 Trial Starts. 22nd March 2022. ... purpose of this research is therefore to assess whether metformin and clemastine.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Publications. Six months of bexarotene reduces the VEP latency, implying remyelination (Brown Lancet Neurol 2021). ... PMID: 36116011; PMCID: PMC9539389. Needham EJ, …. Coles AJ, Menon DK; Cambridge

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Psychosis Clinical Trial. SINAPPS-2 trial. SINAPPS2 is a phase II ongoing clinical trial aiming to test the efficacy and safety of immunotherapy (intravenous immunoglobulin combined

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. ... This new research is a major milestone in our plan to stop MS and we’re incredibly excited about the potential it’s shown for future studies.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Anaphylaxis to alemtuzumab. 20th February 2019. ... PubMed PMID: 30715557. Filed Under: News.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Greg Winter Nobel Prize. 3rd October 2018. ... Wonderful news! Greg Winter today won the Nobel Prize for Chemistry (Shared with George Smith adn Frances Arnold).

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Bexarotene trial published! 19th August 2021. ... It is a mixture of good and bad news! Sadly, we concluded that the drug has too many side-effects to take further as a treatment for people with MS.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Children with MS. We are exploring changes in myelin and nerve health over time in children with demyelinating diseases, such as multiple sclerosis (MS).

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Alemtuzumab Trial Results. These are the “headline results” from the three sponsored clinical trial results.

23 Feb 2024: We enable everyone in the UK to participate in the most crucial research, and we reduce healthcare inequalities. ... To consent to approved research being done at their hospital using their existing information.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Alemtuzumab (Lemtrada). The history of alemtuzumab use in multiple sclerosis.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Survey Studies. Please see below for further details on our studies that are designed to assess patient experience.

23 Feb 2024: Our aim is to train excellent neurologists, with subspeciality expertise, and advanced training in research, education or management. ... We aspire to be flexible, responsive and ambitious. For those interested in neuroscience research, all of the

23 Feb 2024: For more details see our website for Clinical MS Research.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. NHS England algorithm published. 16th September 2018.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Patrick Chinnery appointed as MRC Clinical Director. ... He joins the senior management team and will play a key role in developing, promoting and implementing MRC research programmes, working with

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Treatment Studies. Please see below for further details on our studies that are designed to examine possible treatments.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Honour awarded to Professor Maria Grazia Spillantini.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Measuring Studies. Please see below for further details on our studies that aim to measure disease burden.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Chloe Seikus. Chloe Seikus. Chloe Seikus joined the Department of Clinical Neurosciences as a research assistant in 2020, where she was responsible for recruiting participants to ... the groups’ research

23 Feb 2024: My research interests have focused on how different brain regions communicate, neural plasticity, neural networks, and how abnormalities in these mechanisms can result in pathology.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. AI could detect dementia years before symptoms appear. ... Filed Under: Featured news.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. EMA lifts restriction on alemtuzumab use.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. ... Wonderful news! Greg Winter today won the Nobel Prize for Chemistry (Shared with George Smith adn Frances Arnold).

23 Feb 2024: Quick Links. For staff. For alumni. For business. Colleges & departments. Libraries & facilities. Museums & collections. Email & phone search. Site Search. Site Search. Cambridge Philosophical Society Lecture Monday 27th February. Department of

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Non-disabling relapses count too! 6th March 2023.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Cambridge Centre for Myelin Repair. Alasdair Coles leads the Cambridge Centre for Myelin Repair, alongside Prof. ... CCMR is accompanied by the MS Society Edinburgh Centre for MS Research in the journey to

23 Feb 2024: Department of Clinical Neurosciences. Featured news. ‘Biohybrid’ device could restore function in paralysed limbs. ... Filed Under: Featured news.

23 Feb 2024: Neurotrauma research within Neurosurgery and Anaesthesia aim to improve the understanding of the mechanisms of brain injury to develop novel treatment strategies that improving the clinical outcome. ... We are strongly committed to improve outcomes in

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. FDA warning: stroke after alemtuzumab.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Understanding Studies. Please see below for further details on our studies that aim to further understanding of mitochondrial and neurodegenerative diseases.

23 Feb 2024: Horvath Laboratory. Denisa Hathazi. Denisa Hathazi. PhD. Denisa is a research associate in in the Horvath group since 2019. ... Her current research project studies hereditary mitochondria translational defects affecting muscle and the nervous system.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Alemtuzumab rarely causes sarcoidosis. 17th October 2018. ... doi: 10.1177/1352458518790391. [Epub ahead of print] PubMed PMID: 30307364. Filed Under: News.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. CCMR2 Trial will start in March 2022. ... Check this website for further details near the time. Filed Under: News.

23 Feb 2024: The first question on the GRADSAF application form requires you to choose a course – for research applicants this means you need to specifying which project(s) or supervisors(s) in which ... Identify the research project you wish to apply for by

23 Feb 2024: Current Projects. Pathogenic mechanisms of glycine receptor antibodies. Funding: Wellcome Trust Early Clinical Postdoctoral Research Fellowship (2013-6). ... Funding: British Medical Association Vera Down Award and National Organization for Rare

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Ageing in Multiple Sclerosis (McMurran Group).

23 Feb 2024: Department of Clinical Neurosciences. Featured news. ‘Digital mask’ could protect patients’ privacy in medical records. ... shared. Filed Under: Featured news.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. CCMR One (Bexarotene) Trial fully recruited.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Apathy not depression helps to predict dementia. ... The study provides the basis for further research, including the mechanisms that link apathy, vascular cognitive impairment, and dementia.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Gender bias in clinical trials in MS.

23 Feb 2024: news News http://cscs23.medschl.cam.ac.uk/?p=5060 pProfessor Roger Barker reconsiders the use of foetal cell transplants and explores the next generation of stem cell therapies for patients ... first-reshaping-the-treatment-of-traumatic-brain-injury/

23 Feb 2024: Department of Clinical Neurosciences. Featured news. New research group to help discoveries benefit patients. ... this partnership will bring them the latest research and treatments from the lab.

23 Feb 2024: Laboratory-based research takes place side-by-side with leading Huntington’s disease and Parkinson’s disease research clinics in a highly collaborative environment. ... The focal point of the Centre is the van Geest Building on the University Forvie